This is unpublished
NCCN headquarters building
News

Dr. Paul Nghiem Named Vice Chair for NCCN Panel on Non-Melanoma Skin Cancer Guidelines

April 16, 2025
News Spotlight Image 2
NCCN logo
Paul Nghiem
Pinned
Back to top

Please join us in congratulating Paul Nghiem, MD, PhD, Chair of the UW Department of Dermatology, and Director of the Merkel Cell Carcinoma Collaborative (MC3) Institute, on assuming the role of Vice Chair for the National Comprehensive Cancer Network’s (NCCN) Skin Cancers Excluding Melanoma Guidelines Panel.  Paul Nghiem

In this nationally recognized leadership position, Dr. Nghiem will collaborate with fellow panel members from across the 33 major cancer centers in the US to review, refine, and advance the NCCN Guidelines for Merkel cell carcinoma, basal cell carcinoma, squamous cell carcinoma, and dermatofibrosarcoma protuberans. 

NCCN logoThe NCCN Clinical Practice Guidelines in Oncology provide evidence-based, consensus-driven guidance for cancer management to ensure that all patients receive preventive, diagnostic, therapeutic, and supportive services that are most likely to lead to optimal outcomes. Most insurance companies use the NCCN Guidelines to determine the standard of care, and what services will and will not be reimbursed for each cancer type. 

Recent News

1 day ago
2026 NCCN Guidelines
1 day 21 hours ago
MC3 Member Spotlight: Isaac Brownell, MD, PhD
Isaac Brownell, MD PhD
Group photo with Haroldo
1 day 23 hours ago
Haroldo Rodriguez Successfully Defends PhD Dissertation
Haroldo presenting
Haroldo with piñata
Haroldo with cake